All In MedTech

FDA Clearance Tracker · P010013-S018

NOVASURE IMPEDANCE CONTROLLED ENDOMETRIAL ABLATION SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 29, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P010013-S018
Device name
NOVASURE IMPEDANCE CONTROLLED ENDOMETRIAL ABLATION SYSTEM
Applicant
Hologic, Inc.
Applicant location
Malborough, MA
Received
Feb 20, 2007
Decided
Mar 29, 2007
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P010013

Device type

Device class
Class III

Every decision under product code MNB

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT CYTYC CORPORATION, MARLBOROUGH, MASSACHUSETTS. THE MANUFACTURING STEPS TO BE PERFORMED AT MARLBOROUGH, MASSACHUSETTS WILL BE THE FINAL TEST, LABELING, PACKAGING AND INSPECTION/RELEASE OPERATIONS ASSOCIATED WITH THE RADIO FREQUENCY (RF) CONTROLLER.

Source documents

Other decisions for Hologic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.